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A B S T R A C T
Objective: The aim of this study was to determine the association between previously 
documented risk factors such as recurrent pyelonephritis with the incidence of renal scarring 
after acute pyelonephritis in children. 
Material and methods: Children with acute pyelonephritis who were admitted to the Department 
of Pediatrics of a teaching hospital during 2007-2009 were enrolled in this study. DMSA scans 
were obtained 4-6 months after the last episode of pyelonephritis in all patients. 
Results: A total of 80 children with acute pyelonephritis were enrolled in this study. Most of 
them were girls (77.5%), with a median age of 12 months. Nearly half of the children (n = 44; 
55%) had one or more renal scars. The distribution of gender, CRP level and leukocytosis did 
not differ significantly regardingthe absence or presence of renal scars (p > 0.05). Most of the 
scars occurred in children who had presented with bilateral pyelonephritis (69.4% vs. 18.2%, 
p = 0.001). Most of the patients with renal scars had a positive history of vesicoureteral reflux 
(VUR) (75% vs.13.6%, p = 0.001). The significant roles of recurrent pyelonephritis and presence 
of VUR were further confirmed by multivariate analysis. 
Conclusions: According to our findings, presence of VUR and recurrent pyelonephritis are 
independently associated with a higher incidence of renal scarring. 
Introduction
Urinary tract infection (UTI) is considered the most common 
disease of childhood. UTI may be limited to the bladder, 
cystitis, or may involve the renal parenchyma, acute 
pyelonephritis (APN), defined as fever over 38.5ºC, high 
level of C-reactive protein or erythrocyte sedimentation 
rate, leucocyturia and positive urinary culture.1 The 
clinical presentation of APN may be nonspecific and varies 
according to factors such as the patient’s age and level of 
infection (whether the infection involves kidneys or lower 
urinary tract only). The renal cortical changes are acceptably 
detected by 99mTc-DMSA renal scintigraphy.2 This method 
is applied in two ways: (1) to localize UTI during an attack to 
predict the risk of scarring; (2) to monitor the development of 
new scars; and/or (3) progression of existing scars in a serial 
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follow-up.3,4 The Scientific Committee of Radionuclides in 
Nephrourology tried to compromise on modalities of using 
renal scintigraphy in children with UTI5 depending on the 
health-care delivery system in a specific area; there are 
various types of approaches for managing patients with 
UTI. Moreover, the pediatric nephrologist’s judgment differs 
frequently from that of the nuclear medicine physician and 
considerable discrepancies exist even among the opinions 
of nuclear-medicine specialists. The timing of the 99mTc-
DMSA scan (whether to perform an acute scan, a follow-up 
scan only or both) is still an issue of debate. It is actually 
believed that acute renal scintigraphy is unnecessary due 
to the temporary nature of developed lesions in half of the 
cases. Eventually, they disappear over time.6,7 Also, most 
of the pediatric nephrologists prefer to rely on clinical 
and biological findings in case of complicated UTI rather 
than scintigraphy.8,9 However, it sometimes happens that 
clinical findings and equivocal urine cultures do not favor 
diagnosis, even though the patient may already have UTI 
and renal damage.10,11 This prospective clinical study was 
carried out to indicate any correlation between the incidence 
of renal scarring following acute pyelonephritis and 
previously well-known risk factors such as vesicoureteral 
reflux (VUR), age and recurrent urinary tract infections.
Material and methods
Subjects
The patient sample included all children diagnosed with acute 
pyelonephritis (APN) in the pediatric section of a teaching 
hospital during 2007-2009. Each diagnosis was confirmed 
by a pediatric nephrologist, based on clinical and laboratory 
examinations and DMSA. 
For analytical purposes, the patients were divided into three 
age groups:
Group I: < 12 months;
Group II: 12-48 months;
Group III : > 48 months.
Each patient with APN underwent renal ultrasound and 
voiding cysto-ureterography (VCUG) 4-6 weeks later as part 
of the initial investigation. DMSA scans were obtained at 
least 4-6 months after the last pyelonephritis episode in all 
patients. The grade of VUR was categorized according to the 
International Reflux Committee classification.12 All patients 
were treated with appropriate antibiotic therapy and kept on 
prophylaxis as indicated.
Statistical analysis
The descriptive analysis was performed as appropriate 
(median and range for non-parametric data). Chi-square 
test or Fisher’s exact test were used to analyze categorical 
data and Mann-Whitney test was used to compare two non-
parametric variables. Logistic regression analysis was planned 
considering kidney scar as the dependent variable, and testing 
the covariates resulting significant in the previous univariate 
analysis. p < 0.05 was considered statistically significant.
Results
Demographic findings
A total of 80 children with acute pyelonephritis were enrolled 
in this study. Most of the patients were girls, 77.5%, with a 
median age of 12 months (range 1-156) and more than half 
of them were younger than 1-year-old (n = 45; 56.2%). Almost 
half (n = 44; 55%) reported having APN at least once in their 
past history; however, APN occurred twice and three times in 
25 (31.2%) and 11 (13.8%) children, respectively, during their 
previous admissions. 
The gender distribution did not differ significantly according 
to categorized age groups (p > 0.05).
Clinical and paraclinical findings
One or more renal scars were found in 44 (55%) children. VUR 
was not reported in the majority of the patients (n = 47; 58.8%); 
however, grades I-II VUR were seen in 26 (32.5%) patients and 
the remaining (n = 7; 8.8%) had grades III-V VUR. Only 16 (20%) 
children had neurogenic bladder. The median duration of 
fever was 3 days (range 1-14). Other paraclinical findings were 
as follows: CRP level of more than 6 mg/dL was reported in 61 
(76.2%) children; leukocytosis in 42 (52.5%); and positive culture 
for Escherichia coli was obtained from 69 (86.2%) and the rest of the 
patients had other urinary microbial profiles. 
As shown in Table 1, the distribution of gender, CRP level, 
leukocytosis and urine culture results did not differ significantly 
in relation to the absence or presence of renal scars (p > 0.05). A 
substantial number of patients with renal scars had a positive 
history of VUR in comparison to patients with a negative history 
of VUR (75% vs. 13.6%, respectively, p = 0.001). The frequency of 
children with neurogenic bladder was higher among patients with 
renal scar compared to their counterpart group (30.6% vs. 11.4%, 
respectively, p = 0.049). Furthermore, regarding other variables 
such as the median age (months) of the children, duration of 
fever (days), recurrences of pyelonephritis were significantly 
higher among patients with renal scars (p < 0.05) (Table 1).
As summarized in Table 2, the roles of the recurrences of 
pyelonephritis and presence of VUR were further confirmed by 
the multivariate analysis.
Discussion
Identifying children with UTI who are at increased risk of 
renal damage is one of the major clinical challenges. Several 
complications of renal scarring have been reported including 
hypertension, chronic renal failure and ultimately failure 
to thrive.13
Renal scars are present in 6.1% of children with UTI.14 
Children with APN are substantially vulnerable to renal 
scarring due to the necrosis and fibrosis associated with 
acute inflammation. Actually, it has been shown that 80% of 
defects in APN tend to remain unchanged at least 6 months 
after onset;15 in fact the defects in a binary manner resolve or 
eventually turn into scars. 
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There is a wide variety of factors that might contribute to 
renal damage in children. For this purpose, nephrologists 
generally take some specific clinical signs, such as high fever, 
serious enough to order a diagnostic imaging test.15 Other known 
factors7 that increase the likelihood of renal damage in children 
have been shown to be reflux, CRP and body temperature. 
Obviously, the probability of renal damage in children suffering 
from UTI and high levels of CRP, high fever and dilating reflux 
is up to ten times higher than their counterpart with normal or 
slightly elevated CRP levels, no or mild fever, and no reflux. In 
contrast, this study and another similar study16 did not support 
these results; clearly we did not find any significant difference 
between th two groups of children, with and without scars, 
regarding the levels of CRP and cell counts at the time of APN. 
Despite significantly longer duration of fever in children with 
scars, this variable did not turn out to play an independent role 
in further multivariate analysis. 
The advantages of using 99mTc-DMSA renal scintigraphy 
to evaluate renal sequela after APN have been confirmed 
in various studies.17-19 They demonstrated the efficiency 
of this imaging modality for clinical use in comparison with 
conventional imaging techniques such as ultrasound, CT and 
MRI methodology. Comparatively, ultrasound has not a high 
sensitivity for APN and spiral CT and MRI, with equal sensitivity, 
are not routinely recommended. Further, an abnormal DMSA 
in children was associated with a higher frequency of VUR.19
Variable                   Renal scar p-value
 Present Absent  
Gender
 Boy
 Girl
5 (13.9%)
31 (86.1%)
13 (29.5%)
31 (70.5%)
0.09*
CRP level
 < 6 mg/dL
 > 6 mg/dL
7 (19.4%)
29 (80.6%)
12 (27.3%)
32 (72.7%)
0.41*
Leukocytosis
 Positive
 Negative
17 (47.2%)
19 (52.8%)
21 (47.7%)
23 (52.3%)
0.96*
Urine culture results
 Escherichia coli
 Others
28 (77.8%)
8 (22.2%)
41 (93.2%)
3 (6.8%)
0.057*
VUR grades
 No VUR
 Grades I-II
 Grades III-V
9 (25%)
21 (58.3%)
6 (16.7%)
38 (86.4%)
5 (11.4%)
1 (2.3%)
0.001*
Neurogenic bladder
 Present
 Absent
11 (30.6%)
25 (69.4%)
5 (11.4%)
39 (88.6%)
0.049*
Age (months)
 Median (range) 22 (1.5-156) 9 (1-96) 0.02**
Duration of fever (days)
 Median (range) 3 (1-14) 2 (1-5) 0.019**
Recurrences of pyelonephritis
 Median (range) 2 (1-3) 1 (1-2) 0.001**
**Chi square test (Fisher’s exact test); **Mann-Whitney test; VUR, vesicoureteral reflux.
Variables B S.E. Wald df p-value Exp (B) 95% CI for Exp(B)   
       Lower Upper
VUR grades 2.204 0.565 15.195 1 0.000 9.064 2.992 27.456
Recurrences of pyelonephritis 1.118 0.466 5.755 1 0.016 3.059 1.227 7.627
Constant -2.956 0.804 13.522 1 0.000 0.052
Method: Forward conditional ; Nagelkerke R Square: 0.496; dependent variable: Kidney scar (present: 1, negative: 0); VUR, vesicoureteral reflux.
Table 1 - Comparison of clinical and paraclinical data according to the presence renal scar
Table 2 - Logistic regression model
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There is some evidence that confirm the predominant role of 
high grades VUR (grades IV and V) in the development of renal 
parenchymal damage15,20,21 which strongly predicts the extent 
of renal lesion after an APN.21 Nevertheless, renal lesions have 
been found in lower grades or even in the absence of VUR.21 Our 
results support the latter findings and that is why although some 
follow-up studies considered VUR as a poor predictor of renal 
damage,22 in this study, all of our patients had APN. Therefore, 
high association of VUR and renal scar might be partly due to 
the fact that children with APN and established VUR are more 
vulnerable to renal damage [odds ratio: 9.064; 95% CI: 2.99 to 27.45].
Among our patients, VUR was detected in 41.2% of the 
children. Most of the patients with kidney scars had a positive 
history for VUR (75%). Abnormal DMSA changes were found in 
45% of patients with potential renal scarring, which was higher 
in comparison to data previously reported (5% to 15%).23,24
In addition to the studied factors, there are some other 
risk factors that largely account for the development of 
renal parenchyma scarring which include the route 
of antibiotics administration, the time elapsed before the onset 
of symptoms and initiation of therapy.20 Though we did not 
evaluate in this study, it has been observed that other factors 
such as bacterial virulence, immunodeficiency and anatomic 
or functional abnormalities make children with UTI vulnerable 
to renal scarring.23
Furthermore, we showed that the recurrence of APN is 
independently associated with increased risk for future 
renal scarring. Apart from the presence of VUR, parenchymal 
damage and subsequent scarring following repeated APN is 
almost unavoidable. However, no one can ignore the higher 
probability of scarring triggered by coincident occurrence of 
APN and higher grades of reflux.25
Conclusion
Our study suggests that incidence of renal scarring is higher in 
children with presence of VUR and recurrant pyelonephritis. 
We recommend performing DMSA scan in all children 
with recurrences of pyelonephritis and lower grades of 
vesicoureteral reflux.
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